Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells.

Lee-Chang C, Bodogai M, Martin-Montalvo A, Wejksza K, Sanghvi M, Moaddel R, de Cabo R, Biragyn A.

J Immunol. 2013 Oct 15;191(8):4141-51. doi: 10.4049/jimmunol.1300606. Epub 2013 Sep 16.

2.

Inhibition of lung metastasis by chemokine CCL17-mediated in vivo silencing of genes in CCR4+ Tregs.

Biragyn A, Bodogai M, Olkhanud PB, Denny-Brown SR, Puri N, Ayukawa K, Kanegasaki S, Hogaboam CM, Wejksza K, Lee-Chang C.

J Immunother. 2013 May;36(4):258-67. doi: 10.1097/CJI.0b013e318294357c.

3.

Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor α.

Wejksza K, Lee-Chang C, Bodogai M, Bonzo J, Gonzalez FJ, Lehrmann E, Becker K, Biragyn A.

J Immunol. 2013 Mar 15;190(6):2575-84. doi: 10.4049/jimmunol.1201920. Epub 2013 Feb 13.

4.

Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.

Bodogai M, Lee Chang C, Wejksza K, Lai J, Merino M, Wersto RP, Gress RE, Chan AC, Hesdorffer C, Biragyn A.

Cancer Res. 2013 Apr 1;73(7):2127-38. doi: 10.1158/0008-5472.CAN-12-4184. Epub 2013 Jan 30.

5.

JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients.

Sokołowska B, Nowaczyńska A, Bykowska K, Chocholska S, Wejksza K, Walter-Croneck A, Gromek T, Kowalska AM, Kandefer-Szerszeń M, Dmoszyńska A.

Folia Histochem Cytobiol. 2011;49(2):267-71.

6.

Thymic stromal lymphopoietin is a key mediator of breast cancer progression.

Olkhanud PB, Rochman Y, Bodogai M, Malchinkhuu E, Wejksza K, Xu M, Gress RE, Hesdorffer C, Leonard WJ, Biragyn A.

J Immunol. 2011 May 15;186(10):5656-62. doi: 10.4049/jimmunol.1100463. Epub 2011 Apr 13.

7.

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, Malchinkhuu E, Wersto RP, Biragyn A.

Cancer Res. 2011 May 15;71(10):3505-15. doi: 10.1158/0008-5472.CAN-10-4316. Epub 2011 Mar 28.

8.

Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells.

Wejksza K, Rzeski W, Turski WA.

Pharmacol Rep. 2009 Jul-Aug;61(4):751-6.

9.

Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients.

Zdzisińska B, Wejksza K, Walter-Croneck A, Turski WA, Kandefer-Szerszeń M.

Leuk Res. 2010 Jan;34(1):38-45. doi: 10.1016/j.leukres.2009.06.015. Epub 2009 Jul 10.

PMID:
19596432
10.

Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells.

Rzeski W, Stepulak A, Szymański M, Sifringer M, Kaczor J, Wejksza K, Zdzisińska B, Kandefer-Szerszeń M.

Naunyn Schmiedebergs Arch Pharmacol. 2006 Oct;374(1):11-20. Epub 2006 Sep 9.

PMID:
16964520
11.

Kynurenic acid in human saliva--does it influence oral microflora?

Kuc D, Rahnama M, Tomaszewski T, Rzeski W, Wejksza K, Urbanik-Sypniewska T, Parada-Turska J, Wielosz M, Turski WA.

Pharmacol Rep. 2006 May-Jun;58(3):393-8.

12.

Ammonia at pathophysiologically relevant concentrations activates kynurenic acid synthesis in cultured astrocytes and neurons.

Wejksza K, Rzeski W, Turski WA, Hilgier W, Dybel A, Albrecht J.

Neurotoxicology. 2006 Jul;27(4):619-22. Epub 2006 Feb 14.

PMID:
16481040
13.

Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in oligodendrocyte cell line (OLN-93).

Wejksza K, Rzeski W, Okuno E, Kandefer-Szerszen M, Albrecht J, Turski WA.

Neurochem Res. 2005 Aug;30(8):963-8.

PMID:
16258845
14.

Regulation of proteolytic activity induced by inflammatory stimuli in lung epithelial cells.

Szabó H, Novák Z, Bauer H, Szatmári E, Farkas A, Wejksza K, Orbók A, Wilhelm I, Krizbai IA.

Cell Mol Biol (Noisy-le-grand). 2005 Sep 2;51 Suppl:OL729-35.

PMID:
16171572
15.

Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells.

Krizbai IA, Bauer H, Bresgen N, Eckl PM, Farkas A, Szatmári E, Traweger A, Wejksza K, Bauer HC.

Cell Mol Neurobiol. 2005 Feb;25(1):129-39.

PMID:
15962510
16.

Hyperosmotic mannitol induces Src kinase-dependent phosphorylation of beta-catenin in cerebral endothelial cells.

Farkas A, Szatmári E, Orbók A, Wilhelm I, Wejksza K, Nagyoszi P, Hutamekalin P, Bauer H, Bauer HC, Traweger A, Krizbai IA.

J Neurosci Res. 2005 Jun 15;80(6):855-61.

PMID:
15898100
17.

Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons.

Rzeski W, Kocki T, Dybel A, Wejksza K, Zdzisińska B, Kandefer-Szerszeń M, Turski WA, Okuno E, Albrecht J.

J Neurosci Res. 2005 Jun 1;80(5):677-82.

PMID:
15880762
18.

Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor.

Wejksza K, Rzeski W, Parada-Turska J, Zdzisinska B, Rejdak R, Kocki T, Okuno E, Kandefer-Szerszen M, Zrenner E, Turski WA.

Naunyn Schmiedebergs Arch Pharmacol. 2004 Mar;369(3):300-4. Epub 2004 Feb 10.

PMID:
14770276
19.

Differential effect of betulin and betulinic acid on cytokine production in human whole blood cell cultures.

Zdzisińska B, Rzeski W, Paduch R, Szuster-Ciesielska A, Kaczor J, Wejksza K, Kandefer-Szerszeń M.

Pol J Pharmacol. 2003 Mar-Apr;55(2):235-8.

Supplemental Content

Loading ...
Support Center